GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fujian Cosunter Pharmaceutical Co Ltd (SZSE:300436) » Definitions » Valuation Rank

Fujian Cosunter Pharmaceutical Co (SZSE:300436) Valuation Rank


View and export this data going back to 2015. Start your Free Trial

What is Fujian Cosunter Pharmaceutical Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Fujian Cosunter Pharmaceutical Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Fujian Cosunter Pharmaceutical Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Fujian Cosunter Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Software Park, No. 89, Software Avenue, Block B, Building 10, Zone B, Gulou District, Fujian, Fuzhou, CHN, 350003
Fujian Cosunter Pharmaceutical Co Ltd is a pharmaceutical company engaged in the pharmaceutical production, sales and Research and Development. Its specialized in the field of hepatitis B medicine. Its product includes Fuganding-tenofovir disoproxil fumarate capsule, Enganding-Entecavir Capsules, He Ganding-Lamifuzed tablets and Agandan-adefovir dipivoxil tablets.
Executives
Li Guo Ping Directors, executives
Huang Fu Hu Directors, executives
Li Hong Ming Directors, executives
Guan Jian Hui Executives
Lin Xiao Hui Directors, Directors, and Executives
Ye Li Qing Director
Li Yuan Li Supervisors
Zheng Li Feng Supervisors
Li Guo Dong Directors, executives